Skip to main content
Loading ResearchHub…
Cited by — Multidimensional efficacy characterization of xeligekimab in moderate-to-severe plaque psoriasis: regional responses, treatment targets, and patient-reported outcomes from a randomized controlled trial | ResearchHub - ResearchHub